A systematic review of gastritis as an immune-related adverse event in clinical interventions
Immune checkpoint inhibitors (ICIs) are crucial in cancer treatment, and the associated immune-related adverse events (irAEs) have garnered significant attention, yet reports on associated immune related gastritis are limited. The diagnosis of immune related gastritis remains predominantly exclusion...
Saved in:
| Main Authors: | Fei Su, Wen-Xuan Fan, Yan Zhang, Xiao-Ling Zhang, Yun-Yi Du, Wei-Ling Li, Wen-Qing Hu, Jun Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2408852 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adverse drug events of immune checkpoint inhibitors - a retrospective, descriptive real-world data analysis
by: Lauris Annatha Mariam Auch, et al.
Published: (2025-08-01) -
The neurotoxic effects of immune checkpoint inhibitor therapy for melanoma
by: Lavinia Spain, et al.
Published: (2019-06-01) -
CTLA-4 and PD-1 combined blockade therapy for malignant melanoma brain metastases: mechanisms, challenges, and prospects
by: Jia-Wen Wang, et al.
Published: (2025-07-01) -
Immune-related hepatitis and hypophysitis are associated with superior survival in melanoma patients treated with combined ipilimumab and nivolumab
by: Hifaa Al Remawi, et al.
Published: (2025-12-01) -
Case Report: Tislelizumab-induced insulin-dependent diabetes mellitus: a case report and literature review
by: Panpan Ji, et al.
Published: (2025-07-01)